Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of Neurology

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.10243PMID 12112049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum Toxin Antibody Testing: Comparison between the Immunoprecipitation Assay and the Mouse Diaphragm Assay

  2001cited by this paper
• Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry

  2001cited by this paper
• Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay

  2000cited by this paper
• Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A—A preliminary observation

  2000cited by this paper
• A randomized, double‐blind, placebo‐controlled trial of botulinum A toxin for severe axillary hyperhidrosis

  1999cited by this paper
• Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies

  1999influential reference
• Innervation territories of single sympathetic C fibers in human skin.

  1998cited by this paper
• Spatial extension of sudomotor axon reflex sweating in human skin.

  1998cited by this paper
• A radioimmunoprecipitation assay for antibodies to botulinum A

  1998cited by this paper
• Mouse bioassay versus Western blot assay for botulinurn toxin antibodies Correlation with clinical response

  1998cited by this paper
• The EDB Test—A clinical test for the detection of antibodies to botulinum toxin type A

  1997cited by this paper
• Sudomotor function in sympathetic reflex dystrophy

  1997cited by this paper
• The EBD test--a clinical test for the detection of antibodies to botulinum toxin type A.

  1997cited by this paper
• Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences.

  1997cited by this paper
• Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation

  1996cited by this paper
• Botulinum toxin therapy, immunologic resistance, and problems with available materials

  1996cited by this paper
• Botulinum toxin–a possible new treatment for axillary hyperhidrosis

  1996cited by this paper
• Dose‐response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A

  1996cited by this paper
• Frey's syndrome: treatment with botulinum toxin.

  1995cited by this paper
• Response and immunoresistance to botulinum toxin injections

  1995cited by this paper
• Botulinum toxin: Influence on respiratory heart rate variation

  1995cited by this paper
• Immunogenicity of the neurotoxins of Clostridium botulinum

  1994cited by this paper
• Quantitative assessment of sudomotor activity by capacitance hygrometry

  1993cited by this paper
• Serum antibody production to botulinum A toxin.

  1993cited by this paper
• Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia

  1993cited by this paper
• Botulinum antibodies in dystonic patients treated with type A botulinum toxin

  1993cited by this paper
• Double-blind study of botulinum toxin in spasmodic torticollis.

  1986cited by this paper
• Quantitative sudomotor axon reflex test in normal and neuropathic subjects

  1983cited by this paper
• A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre

  1951cited by this paper

• Immunogenicity of Botulinum Toxin Type A in Different Clinical and Cosmetic Treatment, a Literature Review

  2024cites this paper
• Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications.

  2021cites this paper
• Immunological aspects of botulinum toxin therapy

  2017cites this paper
• Autonomic Effects on the Skin

  2009cites this paper
• Neuroimmunology Of The Skin

  2009cites this paper
• [Clinical relevance of botulinum toxin antibodies].

  2008cites this paper
• Clinical Diagnosis and Management of Dystonia

  2007cites this paper
• Myobloc® for the Treatment of Benign Essential Blepharospasm in Patients Refractory to Botox®

  2006cites this paper
• Ninhydrin sweat test: A simple method for detecting antibodies neutralizing botulinum toxin type A

  2004cites this paper
• Pearls and pitfalls in the therapeutic use of botulinum toxin.

  2004cites this paper
• Clinical impact of antibody formation to botulinum toxin A in children

  2004cites this paper
• Pearls and Pitfalls in the Therapeutic Use of Botulinum Toxin

  2004cites this paper
• Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin

  2003cites this paper
• Chapter 41 Focal injection therapy

  2003cites this paper
• Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.

  2003cites this paper